세계의 유전자 독성 검사 시장 : 제품 유형, 최종 사용자 및 지역별: 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research presents an in-depth analysis of the global Genetic Toxicology Testing Market, offering insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a comprehensive resource for stakeholders, providing detailed data and statistics to navigate the market landscape.

The global genetic toxicology testing market is projected to experience robust growth between 2024 and 2031, with a forecasted CAGR of 13%. The market is estimated to expand from a valuation of USD 1.71 billion in 2024 to USD 4.02 billion by the end of 2031.

Key Insights:

• Estimated Market Value (2024): USD 1.71 Billion
• Projected Market Value (2031): USD 4.02 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 13%

Genetic Toxicology Testing Market - Report Scope:

Genetic toxicology testing plays a critical role in assessing the potential mutagenic and carcinogenic properties of chemical substances. It involves various in vitro and in vivo assays to evaluate DNA damage, chromosomal aberrations, and gene mutations. The increasing focus on safety assessment in pharmaceuticals, chemicals, and food industries drives the demand for genetic toxicology testing.

Regulatory agencies mandate genetic toxicology testing as part of the product development and approval process to ensure consumer safety. Additionally, advancements in testing methodologies, such as high-throughput screening and computational modeling, enhance the efficiency and accuracy of genetic toxicology assessments.

Market Growth Drivers:

The growth of the genetic toxicology testing market is driven by several factors, including stringent regulatory requirements for product safety assessment and the rising prevalence of chronic diseases. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), mandate genetic toxicology testing for new chemical entities and pharmaceuticals to evaluate potential health risks.

Furthermore, the increasing adoption of alternative testing methods, such as in silico modeling and organ-on-a-chip technology, accelerates the testing process while reducing reliance on animal models. This shift towards alternative testing methods aligns with ethical and regulatory considerations and drives market growth.

Market Restraints:

Despite its positive growth trajectory, the genetic toxicology testing market faces challenges, including the high cost of testing procedures and limited awareness among end-users. Genetic toxicology testing requires specialized equipment, skilled personnel, and substantial financial investment, which can deter small and medium-sized enterprises (SMEs) from conducting comprehensive safety assessments.

Additionally, the lack of standardized protocols and variability in test results across laboratories pose challenges for regulatory acceptance and comparability. Addressing these challenges requires collaboration among stakeholders to develop harmonized guidelines and ensure the reliability and reproducibility of genetic toxicology testing.

Market Opportunities:

The genetic toxicology testing market presents significant opportunities for innovation and expansion, particularly in emerging economies and niche applications. With the increasing adoption of precision medicine and personalized healthcare, there is a growing demand for genetic toxicology testing services to assess individual susceptibility to environmental exposures and drug-induced toxicities.

Moreover, advancements in genomics and bioinformatics offer new avenues for biomarker discovery and mechanistic insights into genotoxicity pathways. Integrating omics technologies, such as genomics, transcriptomics, and metabolomics, enhances the predictive power of genetic toxicology testing and enables tailored risk assessments.

Key Questions Addressed in the Report:

• What is the Expected Value CAGR of the Genetic Toxicology Testing Market from 2024 to 2031?
• What are the Key Factors Driving the Growth of the Genetic Toxicology Testing Market?
• Which Region Holds the Largest Market Share in the Genetic Toxicology Testing Market?
• Who are the Key Players in the Global Genetic Toxicology Testing Market?
• What Strategies are Adopted by Leading Companies to Sustain Growth in the Genetic Toxicology Testing Market?

Competitive Landscape and Business Strategies:

Prominent companies in the genetic toxicology testing market include Covance Inc., Eurofins Scientific, Charles River Laboratories International, Inc., and Thermo Fisher Scientific Inc. These companies focus on strategic initiatives such as mergers and acquisitions, collaborations, and product innovations to strengthen their market position and expand their service offerings.

Additionally, investments in research and development facilitate the development of novel testing platforms and methodologies to address evolving regulatory requirements and customer needs. Collaborations with academic institutions and regulatory agencies further enhance technical expertise and regulatory compliance.

Key Companies Profiled:

• Covance Inc.
• Eurofins Scientific
• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific Inc.
• SGS SA
• Bureau Veritas S.A.
• Intertek Group plc
• BioReliance Corporation
• Gentronix Limited
• Cyprotex PLC

Genetic Toxicology Testing Market Segmentation:

By Type

• In Vitro
• In Vivo

By Product

• Reagents & Consumables
• Assays
• Services

By Application

• Pharmaceutical & Biotechnology
• Food Industry
• Cosmetics Industry
• Other

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand-side Trends
• 1.3. Supply-side Trends
• 1.4. Technology Roadmap Analysis
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Background

• 3.1. Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Opportunity
  • 3.1.4. Trends
• 3.2. Scenario Forecast
  • 3.2.1. Demand in Optimistic Scenario
  • 3.2.2. Demand in Likely Scenario
  • 3.2.3. Demand in Conservative Scenario
• 3.3. Opportunity Map Analysis
• 3.4. Investment Feasibility Matrix
• 3.5. PESTLE and Porter's Analysis
• 3.6. Regulatory Landscape
  • 3.6.1. By Key Regions
  • 3.6.2. By Key Countries
• 3.7. Regional Parent Market Outlook

4. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast, 2024-2031

• 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
• 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2031
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Type

• 5.1. Introduction / Key Findings
• 5.2. Historical Market Size Value (US$ Mn) Analysis By Type , 2019-2023
• 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type , 2024-2031
  • 5.3.1. In Vitro
  • 5.3.2. In Vivo
• 5.4. Y-o-Y Growth Trend Analysis By Type , 2019-2023
• 5.5. Absolute $ Opportunity Analysis By Type , 2024-2031

6. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Product

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2019-2023
• 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2024-2031
  • 6.3.1. Reagents & Consumables
  • 6.3.2. Assays
  • 6.3.3. Services
• 6.4. Y-o-Y Growth Trend Analysis By Product, 2019-2023
• 6.5. Absolute $ Opportunity Analysis By Product, 2024-2031

7. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Application

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size Value (US$ Mn) Analysis By Application , 2019-2023
• 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application , 2024-2031
  • 7.3.1. Pharmaceutical & Biotechnology
  • 7.3.2. Food Industry
  • 7.3.3. Cosmetics Industry
  • 7.3.4. Other
• 7.4. Y-o-Y Growth Trend Analysis By Application , 2019-2023
• 7.5. Absolute $ Opportunity Analysis By Application , 2024-2031

8. Global Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 8.1. Introduction
• 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
• 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2031
  • 8.3.1. North America
  • 8.3.2. Latin America
  • 8.3.3. Europe
  • 8.3.4. South Asia
  • 8.3.5. East Asia
  • 8.3.6. Oceania
  • 8.3.7. MEA
• 8.4. Market Attractiveness Analysis By Region

9. North America Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 9.2.1. By Country
    • 9.2.1.1. U.S.
    • 9.2.1.2. Canada
  • 9.2.2. By Type
  • 9.2.3. By Product
  • 9.2.4. By Application
• 9.3. Market Attractiveness Analysis
  • 9.3.1. By Country
  • 9.3.2. By Type
  • 9.3.3. By Product
  • 9.3.4. By Application
• 9.4. Key Takeaways

10. Latin America Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 10.2.1. By Country
    • 10.2.1.1. Brazil
    • 10.2.1.2. Mexico
    • 10.2.1.3. Rest of Latin America
  • 10.2.2. By Type
  • 10.2.3. By Product
  • 10.2.4. By Application
• 10.3. Market Attractiveness Analysis
  • 10.3.1. By Country
  • 10.3.2. By Type
  • 10.3.3. By Product
  • 10.3.4. By Application
• 10.4. Key Takeaways

11. Europe Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 11.2.1. By Country
    • 11.2.1.1. Germany
    • 11.2.1.2. U.K.
    • 11.2.1.3. France
    • 11.2.1.4. Spain
    • 11.2.1.5. Italy
    • 11.2.1.6. Rest of Europe
  • 11.2.2. By Type
  • 11.2.3. By Product
  • 11.2.4. By Application
• 11.3. Market Attractiveness Analysis
  • 11.3.1. By Country
  • 11.3.2. By Type
  • 11.3.3. By Product
  • 11.3.4. By Application
• 11.4. Key Takeaways

12. South Asia Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 12.2.1. By Country
    • 12.2.1.1. India
    • 12.2.1.2. Malaysia
    • 12.2.1.3. Singapore
    • 12.2.1.4. Thailand
    • 12.2.1.5. Rest of South Asia
  • 12.2.2. By Type
  • 12.2.3. By Product
  • 12.2.4. By Application
• 12.3. Market Attractiveness Analysis
  • 12.3.1. By Country
  • 12.3.2. By Type
  • 12.3.3. By Product
  • 12.3.4. By Application
• 12.4. Key Takeaways

13. East Asia Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 13.2.1. By Country
    • 13.2.1.1. China
    • 13.2.1.2. Japan
    • 13.2.1.3. South Korea
  • 13.2.2. By Type
  • 13.2.3. By Product
  • 13.2.4. By Application
• 13.3. Market Attractiveness Analysis
  • 13.3.1. By Country
  • 13.3.2. By Type
  • 13.3.3. By Product
  • 13.3.4. By Application
• 13.4. Key Takeaways

14. Oceania Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 14.2.1. By Country
    • 14.2.1.1. Australia
    • 14.2.1.2. New Zealand
  • 14.2.2. By Type
  • 14.2.3. By Product
  • 14.2.4. By Application
• 14.3. Market Attractiveness Analysis
  • 14.3.1. By Country
  • 14.3.2. By Type
  • 14.3.3. By Product
  • 14.3.4. By Application
• 14.4. Key Takeaways

15. MEA Genetic Toxicology Testing Market Analysis 2019-2023 and Forecast 2024-2031, By Country

• 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 15.2.1. By Country
    • 15.2.1.1. GCC Countries
    • 15.2.1.2. South Africa
    • 15.2.1.3. Israel
    • 15.2.1.4. Rest of MEA
  • 15.2.2. By Type
  • 15.2.3. By Product
  • 15.2.4. By Application
• 15.3. Market Attractiveness Analysis
  • 15.3.1. By Country
  • 15.3.2. By Type
  • 15.3.3. By Product
  • 15.3.4. By Application
• 15.4. Key Takeaways

16. Key Countries Genetic Toxicology Testing Market Analysis

• 16.1. U.S.
  • 16.1.1. Pricing Analysis
  • 16.1.2. Market Share Analysis, 2024
    • 16.1.2.1. By Type
    • 16.1.2.2. By Product
    • 16.1.2.3. By Application
• 16.2. Canada
  • 16.2.1. Pricing Analysis
  • 16.2.2. Market Share Analysis, 2024
    • 16.2.2.1. By Type
    • 16.2.2.2. By Product
    • 16.2.2.3. By Application
• 16.3. Brazil
  • 16.3.1. Pricing Analysis
  • 16.3.2. Market Share Analysis, 2024
    • 16.3.2.1. By Type
    • 16.3.2.2. By Product
    • 16.3.2.3. By Application
• 16.4. Mexico
  • 16.4.1. Pricing Analysis
  • 16.4.2. Market Share Analysis, 2024
    • 16.4.2.1. By Type
    • 16.4.2.2. By Product
    • 16.4.2.3. By Application
• 16.5. Germany
  • 16.5.1. Pricing Analysis
  • 16.5.2. Market Share Analysis, 2024
    • 16.5.2.1. By Type
    • 16.5.2.2. By Product
    • 16.5.2.3. By Application
• 16.6. U.K.
  • 16.6.1. Pricing Analysis
  • 16.6.2. Market Share Analysis, 2024
    • 16.6.2.1. By Type
    • 16.6.2.2. By Product
    • 16.6.2.3. By Application
• 16.7. France
  • 16.7.1. Pricing Analysis
  • 16.7.2. Market Share Analysis, 2024
    • 16.7.2.1. By Type
    • 16.7.2.2. By Product
    • 16.7.2.3. By Application
• 16.8. Spain
  • 16.8.1. Pricing Analysis
  • 16.8.2. Market Share Analysis, 2024
    • 16.8.2.1. By Type
    • 16.8.2.2. By Product
    • 16.8.2.3. By Application
• 16.9. Italy
  • 16.9.1. Pricing Analysis
  • 16.9.2. Market Share Analysis, 2024
    • 16.9.2.1. By Type
    • 16.9.2.2. By Product
    • 16.9.2.3. By Application
• 16.10. India
  • 16.10.1. Pricing Analysis
  • 16.10.2. Market Share Analysis, 2024
    • 16.10.2.1. By Type
    • 16.10.2.2. By Product
    • 16.10.2.3. By Application
• 16.11. Malaysia
  • 16.11.1. Pricing Analysis
  • 16.11.2. Market Share Analysis, 2024
    • 16.11.2.1. By Type
    • 16.11.2.2. By Product
    • 16.11.2.3. By Application
• 16.12. Singapore
  • 16.12.1. Pricing Analysis
  • 16.12.2. Market Share Analysis, 2024
    • 16.12.2.1. By Type
    • 16.12.2.2. By Product
    • 16.12.2.3. By Application
• 16.13. Thailand
  • 16.13.1. Pricing Analysis
  • 16.13.2. Market Share Analysis, 2024
    • 16.13.2.1. By Type
    • 16.13.2.2. By Product
    • 16.13.2.3. By Application
• 16.14. China
  • 16.14.1. Pricing Analysis
  • 16.14.2. Market Share Analysis, 2024
    • 16.14.2.1. By Type
    • 16.14.2.2. By Product
    • 16.14.2.3. By Application
• 16.15. Japan
  • 16.15.1. Pricing Analysis
  • 16.15.2. Market Share Analysis, 2024
    • 16.15.2.1. By Type
    • 16.15.2.2. By Product
    • 16.15.2.3. By Application
• 16.16. South Korea
  • 16.16.1. Pricing Analysis
  • 16.16.2. Market Share Analysis, 2024
    • 16.16.2.1. By Type
    • 16.16.2.2. By Product
    • 16.16.2.3. By Application
• 16.17. Australia
  • 16.17.1. Pricing Analysis
  • 16.17.2. Market Share Analysis, 2024
    • 16.17.2.1. By Type
    • 16.17.2.2. By Product
    • 16.17.2.3. By Application
• 16.18. New Zealand
  • 16.18.1. Pricing Analysis
  • 16.18.2. Market Share Analysis, 2024
    • 16.18.2.1. By Type
    • 16.18.2.2. By Product
    • 16.18.2.3. By Application
• 16.19. GCC Countries
  • 16.19.1. Pricing Analysis
  • 16.19.2. Market Share Analysis, 2024
    • 16.19.2.1. By Type
    • 16.19.2.2. By Product
    • 16.19.2.3. By Application
• 16.20. South Africa
  • 16.20.1. Pricing Analysis
  • 16.20.2. Market Share Analysis, 2024
    • 16.20.2.1. By Type
    • 16.20.2.2. By Product
    • 16.20.2.3. By Application
• 16.21. Israel
  • 16.21.1. Pricing Analysis
  • 16.21.2. Market Share Analysis, 2024
    • 16.21.2.1. By Type
    • 16.21.2.2. By Product
    • 16.21.2.3. By Application

17. Market Structure Analysis

• 17.1. Competition Dashboard
• 17.2. Competition Benchmarking
• 17.3. Market Share Analysis of Top Players
  • 17.3.1. By Regional
  • 17.3.2. By Type
  • 17.3.3. By Product
  • 17.3.4. By Application

18. Competition Analysis

• 18.1. Competition Deep Dive
  • 18.1.1. Thermo Fisher Scientific, Inc.
    • 18.1.1.1. Overview
    • 18.1.1.2. Product Portfolio
    • 18.1.1.3. Profitability by Market Segments
    • 18.1.1.4. Sales Footprint
    • 18.1.1.5. Strategy Overview
      • 18.1.1.5.1. Marketing Strategy
  • 18.1.2. Charles River Laboratories International
    • 18.1.2.1. Overview
    • 18.1.2.2. Product Portfolio
    • 18.1.2.3. Profitability by Market Segments
    • 18.1.2.4. Sales Footprint
    • 18.1.2.5. Strategy Overview
      • 18.1.2.5.1. Marketing Strategy
  • 18.1.3. Laboratory Corp of America Holdings
    • 18.1.3.1. Overview
    • 18.1.3.2. Product Portfolio
    • 18.1.3.3. Profitability by Market Segments
    • 18.1.3.4. Sales Footprint
    • 18.1.3.5. Strategy Overview
      • 18.1.3.5.1. Marketing Strategy
  • 18.1.4. Eurofins Scientific
    • 18.1.4.1. Overview
    • 18.1.4.2. Product Portfolio
    • 18.1.4.3. Profitability by Market Segments
    • 18.1.4.4. Sales Footprint
    • 18.1.4.5. Strategy Overview
      • 18.1.4.5.1. Marketing Strategy
  • 18.1.5. Jubilant Life Sciences Limited
    • 18.1.5.1. Overview
    • 18.1.5.2. Product Portfolio
    • 18.1.5.3. Profitability by Market Segments
    • 18.1.5.4. Sales Footprint
    • 18.1.5.5. Strategy Overview
      • 18.1.5.5.1. Marketing Strategy
  • 18.1.6. Syngene International Limited
    • 18.1.6.1. Overview
    • 18.1.6.2. Product Portfolio
    • 18.1.6.3. Profitability by Market Segments
    • 18.1.6.4. Sales Footprint
    • 18.1.6.5. Strategy Overview
      • 18.1.6.5.1. Marketing Strategy
  • 18.1.7. Gentronix Ltd.
    • 18.1.7.1. Overview
    • 18.1.7.2. Product Portfolio
    • 18.1.7.3. Profitability by Market Segments
    • 18.1.7.4. Sales Footprint
    • 18.1.7.5. Strategy Overview
      • 18.1.7.5.1. Marketing Strategy
  • 18.1.8. Inotiv Inc.
    • 18.1.8.1. Overview
    • 18.1.8.2. Product Portfolio
    • 18.1.8.3. Profitability by Market Segments
    • 18.1.8.4. Sales Footprint
    • 18.1.8.5. Strategy Overview
      • 18.1.8.5.1. Marketing Strategy
  • 18.1.9. Creative Bioarray
    • 18.1.9.1. Overview
    • 18.1.9.2. Product Portfolio
    • 18.1.9.3. Profitability by Market Segments
    • 18.1.9.4. Sales Footprint
    • 18.1.9.5. Strategy Overview
      • 18.1.9.5.1. Marketing Strategy
  • 18.1.10. MB Research Laboratories
    • 18.1.10.1. Overview
    • 18.1.10.2. Product Portfolio
    • 18.1.10.3. Profitability by Market Segments
    • 18.1.10.4. Sales Footprint
    • 18.1.10.5. Strategy Overview
      • 18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology